Ligand validation:6ZXV

EDO: 1,2-ETHANEDIOL

EDO is a Ligand Of Interest in 6ZXV designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZXV_EDO_B_402	40%	85%	0.197	0.908	0.43	0.32	-	-	0	0	100%	1
6ZXV_EDO_A_403	17%	80%	0.159	0.731	0.53	0.32	-	-	0	0	100%	1
6ZXV_EDO_A_402	13%	78%	0.228	0.764	0.58	0.31	-	-	0	0	100%	1
6ZXV_EDO_A_404	6%	76%	0.299	0.73	0.39	0.54	-	-	0	0	100%	1
6ZXW_EDO_G_403	14%	82%	0.303	0.853	0.63	0.18	-	-	2	0	100%	1
6ZXY_EDO_B_501	0%	81%	0.565	0.345	0.59	0.25	-	-	0	0	100%	1
2G8S_EDO_A_3016	100%	84%	0.02	0.992	0.42	0.35	-	-	0	0	100%	0.5
3DPJ_EDO_F_193	100%	76%	0.023	0.995	0.41	0.53	-	-	1	0	100%	1
4EYG_EDO_A_402	100%	81%	0.024	0.995	0.44	0.39	-	-	0	0	100%	1
4NMU_EDO_D_206	100%	92%	0.025	0.997	0.38	0.14	-	-	0	0	100%	1
4Q6J_EDO_A_302	100%	82%	0.013	0.999	0.37	0.42	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.